Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Wu, Zhiyuan ^a   Jiang, Hanqiang ^a   Zhang, Lei ^a   Xu, Xiao ^a   Zhang, Xinju ^a   Kang, Zhihua ^a   Song, Donglei ^a   Zhang, Jin ^a   Guan, Ming ^a   Gu, Yuxiang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLEEDING; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART MUSCLE ISCHEMIA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOYAMOYA DISEASE; NUCLEOTIDE SEQUENCE; RNF213 GENE;

ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MOYAMOYA DISEASE; MUTATION; UBIQUITIN-PROTEIN LIGASES;

EID: 84867861292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048179     Document Type: Article

References (28)

1. Kuroda S, Houkin K, (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7: 1056-1066.
2. Scott RM, Smith ER, (2009) Moyamoya disease and moyamoya syndrome. New Engl J Med 360: 1226-1237.
3. Fukui M, Kono S, Sueishi K, Ikezaki K, (2000) Moyamoya disease. Neuropathology 20: 61-64.
4. Scott RM, Smith ER, (2009) Introduction: moyamoya disease. Neurosurg Focus 26: E1.
5. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, et al. (1997) Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosur 99: S1-S5.
6. Baba T, Houkin K, Kuroda S, (2008) Novel epidemiological features of moyamoya disease. J Neurol Neurosur Ps 79: 900.
7. Uchino K, Johnston SC, Becker KJ, Tirschwell DL, (2005) Moyamoya disease in Washington state and California. Neurology 65: 956.
8. Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, et al. (2010) Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosur 112: 199-203.
9. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, et al. (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39: 42.
10. Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, et al. (2006) Familial occurrence of moyamoya disease: a clinical study. Child Nerv Syst 22: 1143-1148.
11. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T, (1999) Mapping of a familial moyamoya disease gene to chromosome 3p24. 2-p26. Am J Hum Genet 64: 533-537.
12. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M, (2000) Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15: 179.
13. Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, et al. (2004) A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 49: 278-281.
14. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, et al. (2000) Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31: 930-935.
15. Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, et al. (2009) Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 84: 617-627.
16. Liu W, Hashikata H, Inoue K, Matsuura N, Mineharu Y, et al. (2010) A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prevent Med 15: 94-104.
17. Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, et al. (2010) Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir: 1-8.
18. Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, et al. (2008) Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70: 2357-63.
19. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, et al. (2010) A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56: 34-40.
20. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, et al. (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. Plos ONE 6: e22542.
21. Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, et al. (2012) Homozygous c.14576G> A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78: 803-10.
22. Janda P, Bellew J, Veerappan V (2009) Moyamoya Disease: Case Report and Literature Review. J Am Osteopath Assoc 109.
23. Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, et al. (2010) Genetics of Moyamoya disease. J Hum Genet 55: 711-716.
24. Hung CC, Tu YK, Su CF, Lin LS, Shih CJ, (1997) Epidemiological study of moyamoya disease in Taiwan. Clin Neurol Neurosur 99: S23-S25.
25. Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A, (2012) Distribution of Moyamoya Disease Susceptibility Polymorphism p.R4810K in RNF213 in East and Southeast Asian Populations. Neurol Med Chir 52: 299-303.
26. Smith ER, Scott RM, (2010) Moyamoya: Epidemiology, Presentation, and Diagnosis. Neurosurg Clin N Am 21: 543-551.
27. Jea A, Smith ER, Robertson R, Scott RM, (2005) Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics 116: e694.
28. Ibrahimi DM, Tamargo RJ, Ahn ES (2010) Moyamoya disease in children. Child Nerv Syst: 1-12.